Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common stock, par value $0.001 per share
-
Shares outstanding
-
148,275,293
-
Number of holders
-
157
-
Total 13F shares, excl. options
-
77,249,037
-
Shares change
-
+6,257,089
-
Total reported value, excl. options
-
$1,463,933,277
-
Value change
-
+$131,611,867
-
Put/Call ratio
-
237%
-
Number of buys
-
105
-
Number of sells
-
-69
-
Price
-
$18.95
Significant Holders of 89bio, Inc. - Common stock, par value $0.001 per share (ETNB) as of Q2 2023
222 filings reported holding ETNB - 89bio, Inc. - Common stock, par value $0.001 per share as of Q2 2023.
89bio, Inc. - Common stock, par value $0.001 per share (ETNB) has 157 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 77,249,037 shares
of 148,275,293 outstanding shares and own 52% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (11,416,948 shares), BlackRock Inc. (4,650,183 shares), STATE STREET CORP (4,643,191 shares), JANUS HENDERSON GROUP PLC (4,119,918 shares), PICTET ASSET MANAGEMENT SA (3,575,126 shares), VANGUARD GROUP INC (3,369,941 shares), Holocene Advisors, LP (2,638,499 shares), SUVRETTA CAPITAL MANAGEMENT, LLC (2,393,236 shares), FEDERATED HERMES, INC. (2,133,905 shares), and Boxer Capital, LLC (2,100,000 shares).
This table shows the top 157 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.